Search
for
Sort by
Research 391–420 of 529
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Hair Dermal papilla maintain its hair inducing characteristics via autocrine exosomal miR-23a-3p
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- AP-2α/AP-2β transcription factors are key regulators of epidermal homeostasis
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Transcriptome Dynamics Reveal Stage-Specific and Melatonin-Triggered Gene Expression Patterns During The Cashmere Growth Cycle in Capra Hircus
- British Society for Dermatopathology
- Molecular Mechanisms Affecting Development of Animal Fibers and Some Studies on Goats
- Líquen plano pilar e alopecia frontal fibrosante: correlação dos achados clínicos e dermatoscópicos com o grau de inflamação do exame histopatológico
- Oxidative stress and alopecia areata
- 915 Dietary grape powder inhibits atopic dermatitis-like skin lesions in NC/Nga mice
- 916 Gynecologic and hormonal comorbidities of scarring alopecia: A retrospective review
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- 186 Mechanistic insights into Ritlecitinib-mediated immunomodulation in Alopecia Areata
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Current best evidence in pigmentary dermatology
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Interleukin-15 is a hair follicle immune privilege guardian
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- 1432 IL-9/IL-9R signaling as a novel regulator of human hair follicle growth and immune privilege